搜索临床试验以:Histologically confirmed complete response
总计16156个结果
-
Kanto CML Study Group未知
-
Novartis Pharmaceuticals完全的
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)完全的
-
Pomeranian Medical University SzczecinMaria Sklodowska-Curie National Research Institute of Oncology; Regional Oncology Hospital,...未知
-
Instituto Nacional de Cancerologia de MexicoInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran未知
-
Fudan UniversityZhejiang Cancer Hospital; RenJi Hospital; First People Hospital of Zhejiang未知
-
Chinese University of Hong Kong完全的
-
Novartis Pharmaceuticals终止骨髓性白血病美国, 德国, 比利时, 意大利, 西班牙, 大韩民国, 巴西, 日本, 澳大利亚, 捷克共和国
-
Teva Branded Pharmaceutical Products R&D, Inc.完全的复发缓解型多发性硬化症
-
Szeged University未知
-
National University Hospital, SingaporeTan Tock Seng Hospital未知
-
Institut de Cancérologie de la Loire完全的
-
Harriet Shezi Children's Clinic未知确诊感染 HIV 的儿童 | 接受包含标准剂量的 2 NRTIs + LPV/RTV 的 ART 方案 | 在过去 2 至 6 周内成功完成了结核病治疗南非
-
Gruppo Italiano Studio LinfomiRegistro Tumori di Modena; Registro Tumori di Reggio Emilia; Registro Tumori di Parma; registro...完全的
-
Hospital Authority, Hong KongGlaxoSmithKline暂停
-
Oregon Health and Science UniversityAlaska Department of Health and Social Services完全的
-
Bristol-Myers Squibb终止
-
National Taiwan University HospitalNational Science Council, Taiwan完全的
-
AstraZeneca终止Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GC芬兰
-
Grupo Oncológico para el Tratamiento y el Estudio...未知
-
Thallion Pharmaceuticals完全的胶质瘤 | 乳腺癌 | 大肠癌 | 胰腺癌 | 卵巢癌 | 肺癌 | 前列腺癌 | 肿瘤加拿大
-
Solvay Pharmaceuticals完全的子宫内膜异位症俄罗斯联邦, 澳大利亚, 比利时, 保加利亚, 德国, 罗马尼亚, 南非, 乌克兰
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.完全的
-
S.LAB (SOLOWAYS)Center of New Medical Technologies尚未招聘
-
Hadassah Medical OrganizationLondon North West Healthcare NHS Trust尚未招聘新冠肺炎 | 炎症反应
-
Michael HoelscherJimma University; St. Paul's Hospital Millennium Medical College, Ethiopia招聘中COVID-19 复发 | SARS CoV 2 感染 | COVID-19 突破埃塞俄比亚